USPTO serial 88620045
NEOCURA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLACK, MILDRED ELIZABETH
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NEOCURA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rhett V. Barney
Rhett V. Barney LEE & HAYES, PC601 W. RIVERSIDE AVE SUITE 1400SPOKANE, WA 99201UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents for scientific use, slides, solid matrix materials, microfluidic devices and instruction manuals | ACTIVE | — |
| 005 | Diagnostic test kits for scientific use comprising reagents for medical use, slides, solid matrix materials, microfluidic devices and instruction manuals | ACTIVE | — |
| 010 | Diagnostic kits comprising medical instruments for measuring, testing, and analyzing blood, bodily fluids, and tissue | ACTIVE | — |
| 042 | Conducting medical research and providing technical support in the nature of computer software support services to other medical researchers in the fields of oncology, pulmonology, hematology, pathology, and medical genetics; conducting clinical trials and supporting other medical and biomedical researchers by providing medical and scientific research in clinical trials in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (SaaS)services featuring software for use in medical diagnostics using bioinformatics analysis supporting clinicians and researchers in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (SaaS) services featuring software for the analysis of clinical laboratory data, genomics data, and environmental factor data for use in identifying and predicting actionable biomarkers, neoantigens, other molecular data relevant to developing paired diagnostics and therapeutics in the fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; providing software as a service (SaaS) services featuring software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models for utilizing said trained data models for use in biomedical research; providing software as a service (SaaS) services featuring software for detecting and predicting significance of neoantigens and peptides on cells relevant to immunotherapy development; providing medical laboratory services and performing medical testing on tissue samples and body fluids for the detection of genetic and genomic information pertaining to human disease for medical research purposes | ACTIVE | — |
| 044 | Providing medical services including diagnosis, treatment, and care management in fields of oncology, pulmonology, hematology, pathology, immunology, and medical genetics; performing medical testing on tissue samples and body fluids for the detection of genetic and genomic information pertaining to human disease for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes of oncology, pulmonology, hematology, pathology, immunology, and medical genetics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CuraCloud Corporation
- Other trademarks owned by CuraCloud Corporation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NEOCURA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 12, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 11, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 9, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 9, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 9, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 9, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 14, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 9, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 9, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 9, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 9, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 9, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 4, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 2, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 18, 2020 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 3, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 3, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 3, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 3, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 3, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 31, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 30, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 25, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 20, 2019 | NWAP | NEW APPLICATION ENTERED | — |